Clinical trial
Prevention of Decompensation in Liver Cirrhosis
NCT00239096 · Odense University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00239096 |
|---|---|
| Title | Prevention of Decompensation in Liver Cirrhosis |
| Official title | Losartan in the Prevention of Sodium Retention and Ascites in Liver Cirrhosis - a Prospective Randomized Long-Term Study |
| Lead sponsor | Odense University Hospital, Other |
| Collaborators | Lundbeck Foundation University of Southern Denmark Else Poulsen Mindelegat |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcoholic Liver Cirrhosis, Ascites |
| Intervention type | Drug |
| Interventions | losartan (drug) |
| Enrollment | 100 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2011 |
| First posted | Oct 14, 2005 |
| Last update posted | Oct 14, 2005 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: